Hoffman Michael B

SEC Form 4 insider trading activity

Hoffman Michael B has filed 9 SEC Form 4 filings (21 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: May 22, 2026.

On the most recent filing, Hoffman Michael B is listed as Director at Annovis Bio, Inc. Inside the rolling window, Hoffman Michael B reported 7 open-market purchases totaling $4.1M in ANVS and no open-market sales. The largest disclosed transaction in the window is a purchase of 975,610 ANVS shares on Oct 28, 2025, worth $2.0M.

Companies traded

Other insiders at ANVS

Insider Buying

$4.1M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ANVSPurchase$143KMay 22SEC ↗
ANVSPurchase$1.5MApr 3SEC ↗
ANVSPurchase$194KDec 8SEC ↗
ANVSPurchase$160KNov 25SEC ↗
ANVSPurchase$70KNov 21SEC ↗
ANVSPurchase$32KNov 18SEC ↗
ANVSPurchase$2.0MNov 12SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Hoffman Michael B made?

Hoffman Michael B has filed 9 SEC Form 4 filings (21 transaction rows) across 1 company since 2025.

Which companies does Hoffman Michael B trade?

Hoffman Michael B has filed SEC Form 4 disclosures for 1 company, including ANVS.

When was Hoffman Michael B's most recent SEC Form 4 filing?

Hoffman Michael B's most recent SEC Form 4 filing on Tracefour is dated May 22, 2026.

What is Hoffman Michael B's total buy and sell value in the current window?

Inside the rolling retention window, Hoffman Michael B bought $4.1M and sold $0 based on SEC Form 4 filings.

What was Hoffman Michael B's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 975,610 ANVS shares on 2025-10-28, worth $2.0M, per SEC Form 4 filings.